Clincosm LogoSign in Get a demo

neurofibroma, plexiform

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis 1, Neurofibroma, Plexiform Trial run by the NCI (Medication Event Monitoring System (MEMS))

Active, not recruiting
  • Neurofibromatosis 1
  • Neurofibroma, Plexiform
  • Medication Event Monitoring System (MEMS)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

Active, not recruiting
  • Neurofibromatosis 1
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)

Not yet recruiting
  • Neurofibroma
  • Neurofibroma, Plexiform
  • Cryotherapy
  • (no location specified)
Jan 19, 2022

Neurofibroma, Plexiform Trial in Indianapolis (Imatinib Mesylate)

Withdrawn
  • Neurofibroma, Plexiform
  • Imatinib Mesylate
  • Indianapolis, Indiana
    Riley Hospital for Children - Indiana University
Feb 9, 2021

Clinical Sequencing of Cancer and Tissue Repository:

Withdrawn
  • Neoplasms
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 7, 2020

    Neurofibromatosis 1, Neurofibroma, Plexiform Trial in United States (Pirfenidone)

    Completed
    Has Results
    • Neurofibromatosis 1
    • Neurofibroma, Plexiform
    • Birmingham, Alabama
    • +14 more
    Apr 19, 2018

    Neurofibroma, Plexiform, Neurofibromatosis Type I Trial in Germany, United States (tipifarnib, )

    Completed
    Has Results
    • Neurofibroma, Plexiform
    • Neurofibromatosis Type I
    • Birmingham, Alabama
    • +11 more
    Mar 15, 2018